Avadel Pharmaceuticals
  • Recent News
  • Investors
  • About
    • Overview
    • Leadership
    • Board of Directors
    • Business Development
    • Corporate Responsibility
  • Research
    • Clinical Trials
  • Contact Us
  • Call Today
  • Email Us
  • Our Map
    • Avadel Pharmaceuticals
    • 636.449.1830
    • About
      • Overview
      • Leadership
      • Board of Directors
      • Business Development
      • Corporate Responsibility
    • Research
      • Clinical Trials
    • Contact Us
    • Investors
      Careers
636.449.1830
Home > Research Pipeline > Innovative Technologies > LiquiTime®

LiquiTime®

Avadel’s LiquiTime research and development services employ the competitive advantages of its Micropump® technology to allow development of modified/controlled release liquid suspension formulations. Avadel’s LiquiTime services focus on products particularly suitable for dosing children and other patients having issues swallowing tablets or capsules. Unlike the development of resin-complex-based liquid pharmaceuticals, Avadel’s LiquiTime research/development services employ technologies that are not limited to ionic drugs and can be applied to the development of combination products.

Advantages of LiquiTime-developed products:

  • Easy-to-swallow formulations
  • Good mouthfeel
  • Taste-masked
  • Dosing flexibility

Research Pipeline

  • Innovative Technologies
    • Micropump®
    • LiquiTime®
    • Trigger Lock™
    • Medusa™

Contact Avadel Pharmaceuticals Today

Avadel Pharmaceuticals

Helpful Links Site Map | Privacy Policy | Terms and Conditions

  • Overview
  • News & Events
  • Careers
  • Investors
  • Contact Us
16640 Chesterfield Grove Road,
Suite 200,
Saint Louis, MO 63005 |  View Map [+]
https://www.avadel.com/
Site Map | Privacy Policy
http://www.avadel.com

© Avadel. All rights reserved.

0118 AVL WBST TECH LQTM_BM2

Powered by Scorpion